Amgen Inc.
AMGN
$314.85
$0.310.10%
Headlines
5/21/2024
-
SeekingAlpha
5/21/2024
-
Seeking Alpha - Long Ideas
5/21/2024
-
Ticker Report
5/21/2024
-
Ticker Report
5/21/2024
-
InvestorPlace
5/21/2024
-
Ticker Report
5/21/2024
-
Ticker Report
5/21/2024
-
Seeking Alpha: Transcripts
5/21/2024
-
SeekingAlpha
5/20/2024
-
Ticker Report
5/20/2024
-
Ticker Report
5/20/2024
-
InvestorPlace
5/20/2024
-
Seeking Alpha - Healthcare
5/20/2024
-
SeekingAlpha.com: All News
5/20/2024
-
Ticker Report
5/20/2024
-
Ticker Report
5/20/2024
-
FiercePharma
5/20/2024
-
TipRanks Financial Blog
5/20/2024
-
TipRanks Financial Blog
5/20/2024
-
GuruFocus
5/20/2024
-
Zacks Investment Research
5/19/2024
-
The Fly
5/19/2024
-
Ticker Report
5/19/2024
-
PR Newswire
5/19/2024
-
Ticker Report
Filings
Friday, May 3, 2024
Sunday, March 31, 2024
Beginning of August (est)
Price History
Corporate Info
805 447 1000
One Amgen Center Drive
Thousand Oaks, CA 91320-1799
Thousand Oaks, CA 91320-1799
Business Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company’s principal products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and...
more